Diabetes Trials Unit
The Diabetes Trials Unit (DTU) is a clinical trials unit specialising in performing local, national and multinational clinical trials related to treating and managing diabetes and other cardiometabolic and related conditions. We work collaboratively with researchers and organisations to support trials and other studies.
Director
-
Amanda Adler
Professor of Diabetic Medicine and Health Policy
What's new
How to be a good Chief Investigator: one-day UKCRC CTU Network-supported workshops
5 December 2023
Do you know a Chief Investigator who would like a refresher on how to interact with a clinical trials unit (CTU)? Or one who is about to work with you and wants to get up to speed? Or perhaps someone initially considering working with a CTU?
Live to eat and eat to live longer
5 December 2023
New research shows that following the Eatwell Guide recommendations or longevity-associated dietary patterns is likely to improve life expectancy in people with unhealthy or typical dietary patterns in the UK.
First patient randomised on the ISAP study
18 August 2023
Latest publications
-
Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial.
Journal article
Morrow LM. et al, (2023), J Diabetes
-
Orthostatic Hypotension, Hypertension Treatment, and Cardiovascular Disease: An Individual Participant Meta-Analysis.
Journal article
Juraschek SP. et al, (2023), JAMA, 330, 1459 - 1471
-
Timing of SGLT2i initiation after acute myocardial infarction.
Journal article
von Lewinski D. et al, (2023), Cardiovasc Diabetol, 22
-
Aetiology of Type 2 diabetes in people with a 'normal' body mass index: Testing the Personal Fat Threshold Hypothesis.
Journal article
Taylor R. et al, (2023), Clin Sci (Lond)
-
Mitochondrial metabolites predict adverse cardiovascular events in individuals with diabetes.
Journal article
Regan JA. et al, (2023), JCI Insight
|
